Quantcast
Channel: All News Releases
Viewing all articles
Browse latest Browse all 3689

Geneos Therapeutics Announces Positive Phase 1/2 Data for GT-30 Trial of Personalized Therapeutic Cancer Vaccine

$
0
0

Trial has met primary endpoints of safety and immunogenicity and secondary endpoint for efficacy based on response rate Trial data published today in Nature Medicine Selected clinical trial data also presented at the 2024 AACR Annual Meeting PHILADELPHIA, April 7, 2024 /PRNewswire/ --...


Viewing all articles
Browse latest Browse all 3689

Trending Articles